{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:50:08Z","timestamp":1793321408227,"version":"4.5.0"},"reference-count":112,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Adult bone marrow (BM) hematopoietic stem cells (HSCs) are maintained in a quiescent state and sustain the continuous production of all types of blood cells. HSCs reside in a specialized microenvironment the so-called HSC niche, which equally promotes HSC self-renewal and differentiation to ensure the integrity of the HSC pool throughout life and to replenish hematopoietic cells after acute injury, infection or anemia. The processes of HSC self-renewal and differentiation are tightly controlled and are in great part regulated through cellular interactions with classical (e.g. mesenchymal stromal cells) and non-classical niche cells (e.g. immune cells). In myeloid leukemia, some of these regulatory mechanisms that evolved to maintain HSCs, to protect them from exhaustion and immune destruction and to minimize the risk of malignant transformation are hijacked\/disrupted by leukemia stem cells (LSCs), the malignant counterpart of HSCs, to promote disease progression as well as resistance to therapy and immune control. CD4<jats:sup>+<\/jats:sup> regulatory T cells (Tregs) are substantially enriched in the BM compared to other secondary lymphoid organs and are crucially involved in the establishment of an immune privileged niche to maintain HSC quiescence and to protect HSC integrity. In leukemia, Tregs frequencies in the BM even increase. Studies in mice and humans identified the accumulation of Tregs as a major immune-regulatory mechanism. As cure of leukemia implies the elimination of LSCs, the understanding of these immune-regulatory processes may be of particular importance for the development of future treatments of leukemia as targeting major immune escape mechanisms which revolutionized the treatment of solid tumors such as the blockade of the inhibitory checkpoint receptor programmed cell death protein 1 (PD-1) seems less efficacious in the treatment of leukemia. This review will summarize recent findings on the mechanisms by which Tregs regulate stem cells and adaptive immune cells in the BM during homeostasis and in leukemia.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1049301","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T05:49:43Z","timestamp":1667368183000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Regulation of hematopoietic and leukemia stem cells by regulatory T cells"],"prefix":"10.3389","volume":"13","author":[{"given":"Carsten","family":"Riether","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-019-0103-9","article-title":"Haematopoietic stem cell activity and interactions with the niche","volume":"20","author":"Pinho","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cmet.2019.09.010","article-title":"Roles of regulatory T cells in tissue pathophysiology and metabolism","volume":"31","author":"Campbell","year":"2020","journal-title":"Cell Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3475","article-title":"Differential cytokine contributions of perivascular haematopoietic stem cell niches","volume":"19","author":"Asada","year":"2017","journal-title":"Nat Cell Biol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nature13034","article-title":"Direct measurement of local oxygen concentration in the bone marrow of live animals","volume":"508","author":"Spencer","year":"2014","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2010.07.011","article-title":"The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche","volume":"7","author":"Simsek","year":"2010","journal-title":"Cell Stem Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.stem.2011.09.010","article-title":"Metabolic regulation of hematopoietic stem cells in the hypoxic niche","volume":"9","author":"Suda","year":"2011","journal-title":"Cell Stem Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2014.89","article-title":"Regulation of hematopoietic and leukemic stem cells by the immune system","volume":"22","author":"Riether","year":"2015","journal-title":"Cell Death Differ"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.621214","article-title":"Hematopoietic stem cell niche during homeostasis, malignancy, and bone marrow transplantation","volume":"9","author":"Man","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.cell.2019.04.040","article-title":"A cellular taxonomy of the bone marrow stroma in homeostasis and leukemia","volume":"177","author":"Baryawno","year":"2019","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41467-017-02427-x","article-title":"A non-cell-autonomous role for pml in the maintenance of leukemia from the niche","volume":"9","author":"Guarnerio","year":"2018","journal-title":"Nat Commun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2013.06.009","article-title":"Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche","volume":"13","author":"Schepers","year":"2013","journal-title":"Cell Stem Cell"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-348151","article-title":"Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia","volume":"119","author":"Frisch","year":"2012","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.stem.2017.11.006","article-title":"Inhibition of endosteal vascular niche remodeling rescues hematopoietic stem cell loss in AML","volume":"22","author":"Duarte","year":"2018","journal-title":"Cell Stem Cell"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20161418","article-title":"Niche-mediated depletion of the normal hematopoietic stem cell reservoir by Flt3-ITD\u2013induced myeloproliferation","volume":"214","author":"Mead","year":"2017","journal-title":"J Exp Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.celrep.2021.109119","article-title":"Integrated OMICs unveil the bone-marrow microenvironment in human leukemia","volume":"35","author":"Passaro","year":"2021","journal-title":"Cell Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.10.041","article-title":"Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow","volume":"124","author":"Katayama","year":"2006","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2014.06.020","article-title":"Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche","volume":"15","author":"Hanoun","year":"2014","journal-title":"Cell Stem Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/nature13383","article-title":"Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms","volume":"512","author":"Arranz","year":"2014","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12749","article-title":"Cell circuits and niches controlling b cell development","volume":"289","author":"Zehentmeier","year":"2019","journal-title":"Immunol Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830270428\/asset\/1830270428_ftp.pdf?v=1&t=hygdrznc&s=ba10ebe9016e181ebec8afa71273e494b1105362","article-title":"Deregulated TCR alpha beta T cell population provokes extramedullary hematopoiesis in mice deficient in the common gamma chain","volume":"27","author":"Sharara","year":"1997","journal-title":"Eur J Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(02)00319-9","article-title":"Th1 cells regulate hematopoietic progenitor cell homeostasis by production of oncostatin m","volume":"16","author":"Broxmeyer","year":"2002","journal-title":"Immunity"},{"key":"B22","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.stem.2022.04.007","article-title":"Antigen presentation safeguards the integrity of the hematopoietic stem cell pool","volume":"29","author":"Hern\u00e1ndez-Malmierca","year":"2022","journal-title":"Cell Stem Cell"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.26","article-title":"Blocking programmed cell death 1 in combination with adoptive cytotoxic T-cell transfer eradicates chronic myelogenous leukemia stem cells","volume":"29","author":"Riether","year":"2015","journal-title":"Leukemia"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0441-9","article-title":"CD8 + T cells expand stem and progenitor cells in favorable but not adverse risk acute myeloid leukemia","volume":"33","author":"Radpour","year":"2019","journal-title":"Leukemia"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nature10160","article-title":"In vivo imaging of treg cells providing immune privilege to the haematopoietic stem-cell niche","volume":"474","author":"Fujisaki","year":"2011","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.stem.2018.01.017","article-title":"CD150highBone marrow tregs maintain hematopoietic stem cell quiescence and immune privilege via adenosine","volume":"22","author":"Hirata","year":"2018","journal-title":"Cell Stem Cell"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15068","article-title":"Foxp3+ regulatory T cells maintain the bone marrow microenvironment for b cell lymphopoiesis","volume":"8","author":"Pierini","year":"2017","journal-title":"Nat Commun"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-218826","article-title":"Hematopoietic progenitor cell regulation by CD4+CD25+ T cells","volume":"115","author":"Urbieta","year":"2010","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.135681","article-title":"Bone marrow tregs mediate stromal cell function and support hematopoiesis via IL-10","volume":"5","author":"Camacho","year":"2020","journal-title":"JCI Insight"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.151797","article-title":"Tnfrsf4-expressing regulatory T cells promote immune escape of chronic myeloid leukemia stem cells","volume":"6","author":"Hinterbrandner","year":"2021","journal-title":"JCI Insight"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-208181","article-title":"Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia","volume":"114","author":"Zhou","year":"2009","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2019.10.032","article-title":"Blocking migration of regulatory T cells to leukemic hematopoietic microenvironment delays disease progression in mouse leukemia model","volume":"469","author":"Wang","year":"2020","journal-title":"Cancer Lett"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144594","article-title":"An immunocompetent mouse model for MLL\/AF9 leukemia reveals the potential of spontaneous cytotoxic T-cell response to an antigen expressed in leukemia cells","volume":"10","author":"Hasegawa","year":"2015","journal-title":"PloS One"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.04.040","article-title":"XRhythmic modulation of the hematopoietic niche through neutrophil clearance","volume":"153","author":"Casanova-Acebes","year":"2013","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20101688","article-title":"Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche","volume":"208","author":"Chow","year":"2011","journal-title":"J Exp Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-253534","article-title":"Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs","volume":"116","author":"Winkler","year":"2010","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1186\/s12885-020-06961-8","article-title":"Hyperfunction of CD4 CD25 regulatory T cells in de novo acute myeloid leukemia","volume":"20","author":"Wan","year":"2020","journal-title":"BMC Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.10.012","article-title":"IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development","volume":"20","author":"Reynaud","year":"2011","journal-title":"Cancer Cell"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2408","article-title":"Monocytes-macrophages that express \u03b1-smooth muscle actin preserve primitive hematopoietic cells in the bone marrow","volume":"13","author":"Ludin","year":"2012","journal-title":"Nat Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1987","article-title":"Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL-12\/CXCR4 signals","volume":"64","author":"Zou","year":"2004","journal-title":"Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2011.47","article-title":"Bone marrow and the control of immunity","volume":"9","author":"Zhao","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199903)29:03<1051::AID-IMMU1051>3.0.CO;2-Y","article-title":"Characterization of CD4+ T cells in mouse bone marrow. i. increased activated\/memory phenotype and altered TCR vbeta repertoire","volume":"29","author":"Price","year":"1999","journal-title":"Eur J Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903781","article-title":"Different proliferative potential and migratory characteristics of human CD4+ regulatory T cells that express either CD45RA or CD45RO","volume":"184","author":"Booth","year":"2010","journal-title":"J Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-017-2184-6","article-title":"Regulation of normal and leukemic stem cells through cytokine signaling and the microenvironment","volume":"105","author":"Camacho","year":"2017","journal-title":"Int J Hematol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201444532","article-title":"Foxp3+regulatory T cells ensure b lymphopoiesis by inhibiting the granulopoietic activity of effector T cells in mouse bone marrow","volume":"45","author":"Kim","year":"2015","journal-title":"Eur J Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.cell.2017.05.002","article-title":"Regulatory T cells in skin facilitate epithelial stem cell differentiation","volume":"169","author":"Ali","year":"2017","journal-title":"Cell"},{"key":"B47","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.immuni.2019.02.013","article-title":"Treg-cell control of a CXCL5-IL-17 inflammatory axis promotes hair-Follicle-Stem-Cell differentiation during skin-barrier repair","volume":"50","author":"Mathur","year":"2019","journal-title":"Immunity"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01244-9","article-title":"Glucocorticoid signaling and regulatory T cells cooperate to maintain the hair-follicle stem-cell niche","volume":"23","author":"Liu","year":"2022","journal-title":"Nat Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.717903","article-title":"Tissue tregs and maintenance of tissue homeostasis","volume":"9","author":"Shao","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2017.30","article-title":"Tregs: Hype or hope for allogeneic hematopoietic stem cell transplantation","volume":"52","author":"Lussana","year":"2017","journal-title":"Bone Marrow Transpl"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aao4310","article-title":"Tumor-infiltrating human CD4+ regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity","volume":"4","author":"Ahmadzadeh","year":"2019","journal-title":"Sci Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1172\/JCI17702","article-title":"Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia","volume":"112","author":"Trenado","year":"2003","journal-title":"J Clin Invest"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0005","article-title":"Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes","volume":"103","author":"Joffre","year":"2004","journal-title":"Blood"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V78.8.2131.bloodjournal7882131","article-title":"Late failure of autologous marrow grafts in lethally irradiated dogs given anti-class II monoclonal antibody","volume":"78","author":"Greinix","year":"1991","journal-title":"Blood"},{"key":"B55","article-title":"Major histocompatibility complex class II expression is required for posttransplant immunological but not hemopoietic reconstitution in mice","volume":"58","author":"Huss","year":"1994","journal-title":"Transplantation"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01238-w","article-title":"Improving outcomes in chronic myeloid leukemia through harnessing the immunological landscape","volume":"35","author":"Hsieh","year":"2021","journal-title":"Leukemia"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18326","article-title":"Enhanced stimulation of antigen-specific immune responses against nucleophosmin 1 mutated acute myeloid leukaemia by an anti-programmed death 1 antibody","volume":"198","author":"Greiner","year":"2022","journal-title":"Br J Haematol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.120974","article-title":"Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy","volume":"3","author":"Knaus","year":"2018","journal-title":"JCI Insight"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-745992","article-title":"CML patients with deep molecular responses to TKI have restored immune effectors and decreased PD-1 and immune suppressors","volume":"129","author":"Hughes","year":"2017","journal-title":"Blood"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0175-0","article-title":"Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML","volume":"32","author":"Br\u00fcck","year":"2018","journal-title":"Leukemia"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18302","article-title":"Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T-cell phenotype","author":"Harrington","year":"2022","journal-title":"Br J Haematol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.120974:e120974","article-title":"signatures of CD8 + T cell dysfunction in AML patients and their reversibility with response to chemotherapy","volume":"3","author":"Knaus","year":"2018","journal-title":"Ref Inf JCI Insight"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1916206117","article-title":"Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia","volume":"117","author":"Lamble","year":"2020","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.663406","article-title":"Epigenetic silencing of immune-checkpoint receptors in bone marrow- infiltrating T cells in acute myeloid leukemia","volume":"11","author":"Radpour","year":"2021","journal-title":"Front Oncol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41467-019-08871-1","article-title":"Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT","volume":"10","author":"Noviello","year":"2019","journal-title":"Nat Commun"},{"key":"B66","doi-asserted-by":"publisher","first-page":"4232","DOI":"10.1182\/blood.V128.22.4232.4232","article-title":"Mapping the HLA ligandome landscape of chronic myeloid leukemia identifies novel CD8+ and CD4+ T cell-epitopes for immunotherapeutic approaches","volume":"128","author":"Bilich","year":"2016","journal-title":"Blood"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.233","article-title":"Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy","volume":"29","author":"Berlin","year":"2015","journal-title":"Leukemia"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17945-8","article-title":"Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: A multicentre observational trial","volume":"365","author":"Bocchia","year":"2005","journal-title":"Lancet"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2010.141","article-title":"Complete molecular response in CML after p210 BCR-ABL1-derived peptide vaccination","volume":"7","author":"Bocchia","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s40425-018-0367-1","article-title":"Pan-cancer adaptive immune resistance as defined by the tumor inflammation signature (TIS): results from the cancer genome atlas (TCGA)","volume":"6","author":"Danaher","year":"2018","journal-title":"J Immunother Cancer"},{"key":"B71","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/biomedicines6040110","article-title":"Dissecting the immune landscape of acute myeloid leukemia","volume":"6","author":"Davidson-Moncada","year":"2018","journal-title":"Biomed"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2021.101247","article-title":"Immune checkpoint inhibitors in acute myeloid leukemia","volume":"34","author":"Daver","year":"2021","journal-title":"Best Pract Res Clin Haematol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00475","article-title":"Immune biology of acute myeloid leukemia: Implications for immunotherapy","volume":"39","author":"Khaldoyanidi","year":"2021","journal-title":"J Clin Oncol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01253-x","article-title":"T-Cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments","volume":"35","author":"Daver","year":"2021","journal-title":"Leuk"},{"key":"B75","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/ejh.12228","article-title":"Interferon-induced programmed death-ligand 1 (PD-L1\/B7-H1) expression increases on human acute myeloid leukemia blast cells during treatment","volume":"92","author":"Kr\u00f6nig","year":"2014","journal-title":"Eur J Haematol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.656218","article-title":"Immunotherapy in acute myeloid leukemia: Where we stand","volume":"11","author":"Isidori","year":"2021","journal-title":"Front Oncol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25791","article-title":"Elevated frequencies of CD4+CD25+CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia","volume":"129","author":"Shenghui","year":"2011","journal-title":"Int J Cancer"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404522","article-title":"Increased frequencies of CD4(+)CD25(high) t(regs) correlate with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia","volume":"21","author":"Nadal","year":"2007","journal-title":"Leukemia"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2010.09.004","article-title":"Naturally occurring CD4+ CD25+ FOXP3+ T-regulatory cells are increased in chronic myeloid leukemia patients not in complete cytogenetic remission and can be immunosuppressive","volume":"38","author":"Rojas","year":"2010","journal-title":"Exp Hematol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191009","article-title":"Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells","volume":"217","author":"Tanaka","year":"2020","journal-title":"J Exp Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.leukres.2018.01.010","article-title":"Regulatory T cell inhibition by dasatinib is associated with natural killer cell differentiation and a favorable molecular response\u2013the final results of the d-first study","volume":"66","author":"Najima","year":"2018","journal-title":"Leuk Res"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16718","article-title":"Successful treatment-free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells","volume":"191","author":"Irani","year":"2020","journal-title":"Br J Haematol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.clml.2018.03.004","article-title":"Final 3-year results of the dasatinib discontinuation trial in patients with chronic myeloid leukemia who received dasatinib as a second-line treatment","volume":"18","author":"Okada","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13235904","article-title":"Regulatory T cell as a biomarker of treatment-free remission in patients with chronic myeloid leukemia","volume":"13","author":"Fujioka","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0061-T","article-title":"Dasatinib changes immune cell profiles concomitant with reduced tumor growth in several murine solid tumor models","volume":"5","author":"Hekim","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2438","article-title":"Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of ido","volume":"17","author":"Balachandran","year":"2011","journal-title":"Nat Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31896","article-title":"The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia","volume":"125","author":"Williams","year":"2019","journal-title":"Cancer"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","article-title":"Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity","volume":"176","author":"van Galen","year":"2019","journal-title":"Cell"},{"key":"B89","article-title":"Regulatory T cells in pediatric AML are associated with disease load and their serial assessment suggests role in leukemogenesis","volume":"10","author":"Kumar Bansal","year":"2020","journal-title":"Am J Blood Res"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25791","article-title":"Elevated frequencies of CD4(+) CD25(+) CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia","volume":"129","author":"Shenghui","year":"2011","journal-title":"Int J Cancer"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-017-2040-9","article-title":"Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy","volume":"66","author":"Sander","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-3010","article-title":"Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia","volume":"15","author":"Szczepanski","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2005.00537.x","article-title":"Increased population of CD4+CD25highregulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients","volume":"75","author":"Wang","year":"2005","journal-title":"Eur J Haematol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-3594","article-title":"Release of IFN\u03b3 by acute myeloid leukemia cells remodels bone marrow immune microenvironment by inducing regulatory T cells","volume":"28","author":"Corradi","year":"2022","journal-title":"Clin Cancer Res"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01710","article-title":"PD-L1 is expressed and promotes the expansion of regulatory T cells in acute myeloid leukemia","volume":"11","author":"Dong","year":"2020","journal-title":"Front Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01375-2","article-title":"Regulatory T cells promote the stemness of leukemia stem cells through IL10 cytokine-related signaling pathway","volume":"36","author":"Xu","year":"2022","journal-title":"Leukemia"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02227\/full","article-title":"Acute myeloid leukemia cells express ICOS ligand to promote the expansion of regulatory T cells","volume":"9","author":"Han","year":"2018","journal-title":"Front Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01918","article-title":"ATP release from chemotherapy-treated dying leukemia cells elicits an immune suppressive effect by increasing regulatory T cells and tolerogenic dendritic cells","volume":"8","author":"Lecciso","year":"2017","journal-title":"Front Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1182\/bloodadvances.2021004878","article-title":"An IDO1 -related immune gene signature predicts overall survival in acute myeloid leukemia","volume":"6","author":"Ragaini","year":"2022","journal-title":"Blood Adv"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15548","article-title":"Mesenchymal COX2-PG secretome engages NR4A-WNT signalling axis in haematopoietic progenitors to suppress anti-leukaemia immunity","volume":"183","author":"Wu","year":"2018","journal-title":"Br J Haematol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2001.01692.x","article-title":"Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function\u2013implications for the adoptive immunotherapy of leukaemia","volume":"126","author":"Orleans-Lindsay","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29563","article-title":"Regulatory T cells-derived IL-35 promotes the growth of adult acute myeloid leukemia blasts","volume":"137","author":"Tao","year":"2015","journal-title":"UICC Int J Cancer IJC"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501291","article-title":"Cells by cross-reactive induced regulatory T adaptive immunity to leukemia is inhibited","volume":"195","author":"Farrar Pauken","year":"2022","journal-title":"J Immunol Ref"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1808777","article-title":"Immune escape of relapsed AML cells after allogeneic transplantation","volume":"379","author":"Christopher","year":"2018","journal-title":"N Engl J Med"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0400-z","article-title":"Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation","volume":"25","author":"Toffalori","year":"2019","journal-title":"Nat Med"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0762","article-title":"Anti-CTLA-4 immunotherapy does not deplete FOXP3+ regulatory T cells (Tregs) in human cancers","volume":"25","author":"Sharma","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1097\/01.cji.0000175468.19742.10","article-title":"Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma","volume":"28","author":"Attia","year":"2005","journal-title":"J Immunother"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1601202","article-title":"Ipilimumab for patients with relapse after allogeneic transplantation","volume":"375","author":"Davids","year":"2016","journal-title":"N Engl J Med"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.03.013","article-title":"Fc-optimized anti-CD25 depletes tumor-infiltrating regulatory T cells and synergizes with PD-1 blockade to eradicate established tumors","volume":"46","author":"Arce Vargas","year":"2017","journal-title":"Immunity"},{"key":"B110","doi-asserted-by":"publisher","first-page":"106385","DOI":"10.1016\/j.leukres.2020.106385","article-title":"Camidanlumab tesirine, an antibody-drug conjugate, in relapsed\/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study","volume":"95","author":"Goldberg","year":"2020","journal-title":"Leuk Res"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1570778","article-title":"Depleting T regulatory cells by targeting intracellular Foxp3 with a TCR mimic antibody","volume":"8","author":"Dao","year":"2019","journal-title":"Oncoimmunology"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003892","article-title":"Direct targeting of FOXP3 in tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer","volume":"10","author":"Revenko","year":"2022","journal-title":"J Immunother Cancer"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1049301\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T05:49:47Z","timestamp":1667368187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1049301\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":112,"alternative-id":["10.3389\/fimmu.2022.1049301"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1049301","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,2]]},"article-number":"1049301"}}